Related Experiment Video

Updated: Jul 13, 2026

Bioparticle Microarrays for Chemotactic and Molecular Analysis of Human Neutrophil Swarming in vitro
11:21

Bioparticle Microarrays for Chemotactic and Molecular Analysis of Human Neutrophil Swarming in vitro

Published on: February 16, 2020

Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases

Kazuki Aomatsu1, Takayuki Kato, Hisakazu Fujita

  • 1Department of Physiology, Osaka City University Graduate School of Medicine, Ashai-machi, Abeno-ku, Osaka, Japan.

Immunology
|July 31, 2007
PubMed

Insights

Toll-like receptor (TLR) agonists like LPS and P3CSK4 enhance human neutrophil random migration, not chemotaxis, by activating ERK and p38 MAPK signaling pathways. This enhanced motility is sustained for over 80 minutes.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Neutrophils are critical immune cells involved in host defense.
  • Toll-like receptors (TLRs) play a key role in innate immunity by recognizing pathogen-associated molecular patterns.
  • Neutrophil migration is essential for their function in inflammatory sites.

Purpose of the Study:

  • To investigate the effect of Toll-like receptor (TLR) agonists on human neutrophil migratory responses.
  • To elucidate the signaling pathways involved in TLR-mediated neutrophil migration.
  • To determine if TLR agonist pre-exposure affects subsequent chemotactic responses.

Main Methods:

  • Videomicroscopy was used to analyze human neutrophil migration.
  • Neutrophils were stimulated with lipopolysaccharide (LPS, TLR4 agonist) and P3CSK4 (TLR2 agonist).
  • Inhibitors of mitogen-activated protein kinases (MAPKs), including U0126 and SB203580, were used to study signaling pathways.

Main Results:

  • TLR agonists (LPS and P3CSK4) significantly enhanced random neutrophil migration, but not directed migration (chemotaxis).
  • Enhanced motility was observed within 10 minutes and sustained for over 80 minutes post-stimulation.
  • TLR stimulation activated extracellular signal-regulated kinase (ERK) and p38 MAPK, which were crucial for the enhanced migration, as indicated by suppression with U0126 and SB203580.

Conclusions:

  • TLR agonists stimulate human neutrophil migration primarily through increased random motility, mediated by ERK and p38 MAPK activation.
  • Pre-exposure to TLR agonists does not impair subsequent chemotaxis induced by N-formyl-methionyl-leucyl-phenylalanine (FMLP) or platelet-activating factor (PAF).
  • These findings highlight a distinct mechanism by which TLRs modulate neutrophil behavior, impacting inflammatory responses.

More Related Videos

Detecting Migration and Infiltration of Neutrophils in Mice10:33

Detecting Migration and Infiltration of Neutrophils in Mice

Published on: February 6, 2020

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists11:32

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists

Published on: October 18, 2024

Related Concept Videos

Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Inflammation01:38

Inflammation

Overview